Association of sodium‐glucose cotransporter 2 inhibitors with risk of incident dementia and all‐cause mortality in older patients with type 2 diabetes: A retrospective cohort study using the TriNetX US collaborative networks

医学 危险系数 痴呆 内科学 队列 回顾性队列研究 2型糖尿病 二甲双胍 队列研究 倾向得分匹配 相对风险 糖尿病 置信区间 内分泌学 胰岛素 疾病
作者
Yen‐Wei Pai,I‐Chieh Chen,Jun‐Fu Lin,Xiaohong Chen,Hsin‐Hua Chen,Ming‐Hong Chang,Jin‐An Huang,Ching‐Heng Lin
出处
期刊:Diabetes, Obesity and Metabolism [Wiley]
被引量:1
标识
DOI:10.1111/dom.15918
摘要

Abstract Background Limited evidence exists to support any specific medication over others to prevent dementia in older patients with type 2 diabetes (T2D). We investigated whether treatment with sodium‐glucose cotransporter 2 (SGLT‐2) inhibitors is associated with a lower risk of incident dementia and all‐cause mortality, relative to dipeptidyl peptidase‐4 (DPP‐4) inhibitors and glucagon‐like peptide‐1 receptor agonists (GLP‐1 RA). Methods In this retrospective, active‐comparator cohort study, we used data from the TriNetX electronic health records network. Our primary cohort comprised patients with T2D aged ≥50 years, registered between January 2012 and December 2022. Patients with a history of dementia were excluded. We used Kaplan–Meier survival analysis to estimate the incidence of dementia and all‐cause mortality in our cohort after they had used glucose‐lowering drugs for at least 12 months. Propensity score matching was performed to balance the SGLT‐2 inhibitor, DPP‐4 inhibitor and GLP‐1 RA cohorts. Subgroup analyses for sex and age were also conducted. Results Our first cohort comprised 193 948 patients treated with metformin and SGLT‐2 inhibitors and an equal number of patients treated with metformin and DPP‐4 inhibitors. In this cohort, the risk of dementia and all‐cause mortality was lower in patients treated with SGLT‐2 inhibitors than in those treated with DPP‐4 inhibitors (hazard ratio [HR]: 0.62, 95% confidence interval [CI]: 0.59–0.65, for dementia; HR: 0.54, 95% CI: 0.52–0.56, for all‐cause mortality). Our second cohort comprised 165 566 patients treated with metformin and SGLT‐2 inhibitors and an equal number of patients treated with metformin and GLP‐1 RAs. In this cohort, the risk of dementia and all‐cause mortality was lower in those treated with SGLT‐2 inhibitors than in those treated with GLP‐1 RAs (HR: 0.92, 95% CI: 0.87–0.98, for dementia; HR: 0.88, 95% CI: 0.85–0.91, for all‐cause mortality). Conclusions The use of SGLT‐2 inhibitor was associated with a lower risk of incident dementia and all‐cause mortality in older adults with T2D compared to DPP‐4 inhibitor and GLP‐1 RA.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
cora完成签到 ,获得积分10
1秒前
徐伟康完成签到 ,获得积分10
1秒前
Minicoper完成签到,获得积分10
12秒前
科研通AI5应助普鲁卡因采纳,获得10
12秒前
111完成签到 ,获得积分10
12秒前
奥特曼完成签到 ,获得积分10
12秒前
苏苏完成签到,获得积分10
13秒前
大橙子完成签到,获得积分10
13秒前
kelite完成签到 ,获得积分10
14秒前
火星上的雨柏完成签到 ,获得积分10
15秒前
JY完成签到,获得积分10
16秒前
知行合一完成签到 ,获得积分10
16秒前
19秒前
19秒前
笑林完成签到 ,获得积分10
20秒前
wwl完成签到,获得积分10
20秒前
娟娟完成签到 ,获得积分10
21秒前
Hollen完成签到 ,获得积分10
21秒前
janejane发布了新的文献求助10
22秒前
23秒前
32429606完成签到 ,获得积分10
23秒前
24秒前
普鲁卡因发布了新的文献求助10
26秒前
发个15分的完成签到 ,获得积分10
28秒前
28秒前
wellyou发布了新的文献求助10
28秒前
量子星尘发布了新的文献求助10
33秒前
自由的鹏涛完成签到,获得积分20
36秒前
37秒前
在水一方应助Nayvue采纳,获得10
37秒前
40秒前
Ryan完成签到,获得积分10
41秒前
General完成签到 ,获得积分10
41秒前
谦让汝燕完成签到,获得积分10
43秒前
wellyou完成签到,获得积分10
44秒前
mint完成签到,获得积分10
46秒前
afli完成签到 ,获得积分0
49秒前
50秒前
Yy完成签到 ,获得积分10
53秒前
Nayvue发布了新的文献求助10
55秒前
高分求助中
【提示信息,请勿应助】关于scihub 10000
Les Mantodea de Guyane: Insecta, Polyneoptera [The Mantids of French Guiana] 3000
徐淮辽南地区新元古代叠层石及生物地层 3000
The Mother of All Tableaux: Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 3000
Handbook of Industrial Diamonds.Vol2 1100
Global Eyelash Assessment scale (GEA) 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 550
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 4038128
求助须知:如何正确求助?哪些是违规求助? 3575831
关于积分的说明 11373827
捐赠科研通 3305610
什么是DOI,文献DOI怎么找? 1819255
邀请新用户注册赠送积分活动 892655
科研通“疑难数据库(出版商)”最低求助积分说明 815022